Tioga Cardiovascular Introduces Groundbreaking Luna™ TMVR System in First Human Trials

LOS GATOS, Calif., October 23, 2024 /PRNewswire/ — Tioga Cardiovascular, part of the Shifamed portfolio, has achieved a significant milestone by successfully implementing its Luna™ transcatheter mitral valve replacement (TMVR) system in humans for the first time. The initial procedures, carried out using the 28 Fr. Luna™ system, resulted in excellent post-operative outcomes for the patients involved. These pivotal first cases were conducted by Dr. Adrian Ebner in Asuncion, Paraguay, and Dr. Irakli Gogorishvili in Tbilisi, Republic of Georgia, supported by a team of leading U.S. physicians including Drs. Azeem Latib, Susheel Kodali, Edwin C.W. Ho, Gagan Singh, and Vinnie Bapat.

Dr. Azeem Latib from New York's Montefiore Medical Center expressed excitement about the Luna TMVR system's capabilities, particularly its design to tackle the inherent complexities of mitral valve procedures. "Introducing this advanced system into clinical practice marks a thrilling development in the field," he stated.

Tioga's President and CEO, Mike Dineen, reflected on the significance of these first trials, emphasizing the collaborative effort involved. "These initial cases represent a crucial step forward for Tioga, and I am immensely grateful to our team and clinical partners for their unwavering dedication to excellence," Dineen said. He also noted that more details about the Luna TMVR system would be unveiled at the upcoming Transcatheter Cardiovascular Therapeutics (TCT) conference.

The Luna TMVR system will be highlighted in a dedicated session on innovative transcatheter mitral valve replacement technologies at the TCT conference, scheduled for October 29 in Washington, DC.

About Tioga Cardiovascular, Inc.: A private entity within Shifamed LLC's portfolio, Tioga Cardiovascular focuses on simplifying mitral valve replacement procedures through innovative, less invasive technologies. More information can be found at www.tiogamed.com.

About Shifamed, LLC: Shifamed LLC, established by entrepreneur Amr Salahieh, operates as a specialized hub aiming to streamline the development and market launch of medical solutions, enhancing patient outcomes globally. Learn more at www.shifamed.com.

Previous
Previous

Samay Triumphs at MedTech 2024: A Historic First for Latin America

Next
Next

PAVmed Achieves Global Healthcare Milestone with PortIO™ Trials in Colombia